Pieter Voorn

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.

H. Groenewegen, H. Groenewegen, J. C. Stoof, 1999, European journal of pharmacology.

Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatment

C. Pennartz, R. Joosten, P. Voorn, 2007, European Neuropsychopharmacology.

Anatomical evidence for direct connections between the shell and core subregions of the rat nucleus accumbens

C. Pennartz, J. Deniau, H. Groenewegen, 2005, Neuroscience.